Ajanta Pharma Limited (BOM: 532331)

Market Cap	359.76B
Revenue (ttm)	44.91B
Net Income (ttm)	8.75B
Shares Out	n/a
EPS (ttm)	69.60
PE Ratio	41.12
Forward PE	n/a
Dividend	54.00 (1.89%)
Ex-Dividend Date	Nov 6, 2024

Volume	932
Average Volume	5,017
Open	2,860.10
Previous Close	2,860.30
Day's Range	2,852.60 - 2,898.05
52-Week Range	2,003.55 - 3,485.75
Beta	n/a
RSI	48.47
Earnings Date	Jan 27, 2025

About Ajanta Pharma

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited ...

• Industry: Pharmaceutical Preparations
• Founded: 1973
• Employees: 8,073
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532331

Financial Performance

In 2023, Ajanta Pharma's revenue was 42.09 billion, an increase of 12.45% compared to the previous year's 37.43 billion. Earnings were 8.16 billion, an increase of 38.81%.